163 related articles for article (PubMed ID: 15888029)
21. Oral pirfenidone protects against fibrosis by inhibiting fibroblast proliferation and TGF-β signaling in a murine colitis model.
Li G; Ren J; Hu Q; Deng Y; Chen G; Guo K; Li R; Li Y; Wu L; Wang G; Gu G; Li J
Biochem Pharmacol; 2016 Oct; 117():57-67. PubMed ID: 27498142
[TBL] [Abstract][Full Text] [Related]
22. Pirfenidone diminishes cyclophosphamide-induced lung fibrosis in mice.
Kehrer JP; Margolin SB
Toxicol Lett; 1997 Feb; 90(2-3):125-32. PubMed ID: 9067480
[TBL] [Abstract][Full Text] [Related]
23. Pirfenidone inhibits transforming growth factor-β1-induced fibrogenesis by blocking nuclear translocation of Smads in human retinal pigment epithelial cell line ARPE-19.
Choi K; Lee K; Ryu SW; Im M; Kook KH; Choi C
Mol Vis; 2012; 18():1010-20. PubMed ID: 22550395
[TBL] [Abstract][Full Text] [Related]
24. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
Transplant Proc; 2005; 37(1):130-3. PubMed ID: 15808571
[TBL] [Abstract][Full Text] [Related]
25. Pirfenidone Attenuates Renal Tubulointerstitial Fibrosis through Inhibiting miR-21.
Bi L; Huang Y; Li J; Yang X; Hou G; Zhai P; Zhang Q; Alhaji AA; Yang Y; Liu B
Nephron; 2022; 146(1):110-120. PubMed ID: 34724669
[TBL] [Abstract][Full Text] [Related]
26. Arginase acts as an alternative pathway of L-arginine metabolism in experimental colon anastomosis.
Witte MB; Vogt N; Stuelten C; Gotoh T; Mori M; Becker HD
J Gastrointest Surg; 2003; 7(3):378-85. PubMed ID: 12654563
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease.
Romanska HM; Ikonen TS; Bishop AE; Morris RE; Polak JM
J Pathol; 2000 May; 191(1):71-7. PubMed ID: 10767722
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of nitric oxide synthase and arginase in the induction of a Peyronie's-like condition in the rat.
Bivalacqua TJ; Champion HC; Leungwattanakij S; Yang DY; Hyun JS; Abdel-Mageed AB; Sikka SC; Kadowitz PJ; Hellstrom WJ
J Androl; 2001; 22(3):497-506. PubMed ID: 11330651
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
30. Transforming growth factor-beta1 and lung allograft fibrosis.
El-Gamel A; Awad M; Sim E; Hasleton P; Yonan N; Egan J; Deiraniya A; Hutchinson IV
Eur J Cardiothorac Surg; 1998 Apr; 13(4):424-30. PubMed ID: 9641342
[TBL] [Abstract][Full Text] [Related]
31. Pirfenidone: a potential new therapy for restrictive allograft syndrome?
Vos R; Verleden SE; Ruttens D; Vandermeulen E; Yserbyt J; Dupont LJ; Van Raemdonck DE; De Raedt N; Gheysens O; De Jong PA; Verleden GM; Vanaudenaerde BM
Am J Transplant; 2013 Nov; 13(11):3035-40. PubMed ID: 24102752
[TBL] [Abstract][Full Text] [Related]
32. Pirfenidone inhibits the expression of HSP47 in TGF-beta1-stimulated human lung fibroblasts.
Nakayama S; Mukae H; Sakamoto N; Kakugawa T; Yoshioka S; Soda H; Oku H; Urata Y; Kondo T; Kubota H; Nagata K; Kohno S
Life Sci; 2008 Jan; 82(3-4):210-7. PubMed ID: 18093617
[TBL] [Abstract][Full Text] [Related]
33. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
34. Arginase and pulmonary diseases.
Maarsingh H; Pera T; Meurs H
Naunyn Schmiedebergs Arch Pharmacol; 2008 Aug; 378(2):171-84. PubMed ID: 18437360
[TBL] [Abstract][Full Text] [Related]
35. Blockade of the L-arginine/NO synthase pathway worsens hepatic apoptosis and liver transplant preservation injury.
Yagnik GP; Takahashi Y; Tsoulfas G; Reid K; Murase N; Geller DA
Hepatology; 2002 Sep; 36(3):573-81. PubMed ID: 12198649
[TBL] [Abstract][Full Text] [Related]
36. Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.
Wu YH; Li XW; Li WQ; Li XH; Li YJ; Hu GY; Liu ZQ; Li D
Eur J Pharmacol; 2016 Feb; 773():42-50. PubMed ID: 26821114
[TBL] [Abstract][Full Text] [Related]
37. Pirfenidone alleviates pulmonary fibrosis in vitro and in vivo through regulating Wnt/GSK-3β/β-catenin and TGF-β1/Smad2/3 signaling pathways.
Lv Q; Wang J; Xu C; Huang X; Ruan Z; Dai Y
Mol Med; 2020 May; 26(1):49. PubMed ID: 32448163
[TBL] [Abstract][Full Text] [Related]
38. Reduction of chronic rejection of renal allografts by anti-transforming growth factor-β antibody therapy in a rat model.
Guan Q; Li S; Gao S; Chen H; Nguan CY; Du C
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F199-207. PubMed ID: 23552866
[TBL] [Abstract][Full Text] [Related]
39. Verbascoside and isoverbascoside ameliorate transforming growth factor β1-induced collagen expression by lung fibroblasts through Smad/non-Smad signaling pathways.
Chen CY; Tung HY; Tseng YF; Huang JS; Shi LS; Ye YL
Life Sci; 2022 Nov; 308():120950. PubMed ID: 36100079
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of arginase expression in wound-derived fibroblasts.
Witte MB; Barbul A; Schick MA; Vogt N; Becker HD
J Surg Res; 2002 Jun; 105(1):35-42. PubMed ID: 12069499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
